Despite a modest rise in annual revenue, Mudajaya Group Berhad (KLSE:MUDAJYA) has seen its share price plummet 65% over five years, leaving long-term investors deep in the red. We examine the disconnect between business performance and market sentiment.
As income investors look toward 2026, a stark choice emerges between Energy Transfer's tempting 7.1% yield and Enterprise Products Partners' quarter-century record of reliable payouts. We examine the risk-reward calculus behind the numbers.
Blue Bird Corporation (BLBD) is poised to release its latest quarterly results after Wednesday's market close. Investors will be watching to see if the manufacturer can maintain its pattern of outperforming Wall Street's forecasts amidst a mixed landscape for heavy equipment peers.
CME Group is set to report fourth-quarter earnings Wednesday morning, with analysts forecasting a 7.8% revenue increase. The derivatives exchange operator's performance may signal broader capital markets health as peers post mixed results.
Arcellx shares have delivered stellar multi-year gains, prompting investors to question if the rally still has room to run. A deep dive into valuation metrics reveals a complex picture, with discounted cash flow models pointing to significant upside while price-to-book ratios suggest a more cautious stance.
Silgan Holdings is set to report fourth-quarter earnings Wednesday morning, with Wall Street eyeing slowing revenue growth and the company's ability to outperform in a mixed industrial packaging landscape.
Eli Lilly's $3.5 billion investment in a new Pennsylvania facility for injectable weight-loss drugs, including retatrutide, spotlights its aggressive expansion in the obesity market. This strategic move, coupled with strong analyst sentiment and upcoming earnings, intensifies focus on the company's growth trajectory and premium valuation.
Amgen has terminated its collaboration with Kyowa Kirin on the atopic dermatitis drug rocatinlimab, handing full development rights back to the Japanese partner. The strategic shift comes as Amgen's stock trades above most fair value estimates, raising questions about its current valuation amid pipeline recalibration.
Shares of cybersecurity firm Gen Digital have tumbled over 7% in a week, pushing its valuation metrics below industry averages. A deep dive into its cash flows and earnings multiples suggests the market may be undervaluing the consumer digital safety provider.
Energy Recovery (ERII) sees its price target raised to $23 by analysts, reflecting increased confidence in the adoption timeline for its CO2 refrigeration technology, despite stable core valuation metrics. The shift underscores a nuanced market narrative focused on execution rather than a fundamental change in long-term prospects.
Stanley Black & Decker announces key leadership changes, appointing a new General Counsel and adding fresh expertise to its board. The moves signal a deeper focus on governance and operational oversight as the company navigates its financial turnaround.
U.S. immigration authorities will not conduct enforcement actions at this Sunday's Super Bowl, sources tell Reuters, as the event becomes a flashpoint in the nation's heated immigration debate.
The Hennepin County Medical Examiner has ruled the death of Alex Pretti, a 37-year-old nurse shot by federal agents during a Minneapolis immigration protest, a homicide by multiple gunshot wounds, as witness accounts and footage challenge the official narrative of the incident.
Aerospace and defense component maker Woodward, Inc. (WWD) is commanding investor attention following a robust first-quarter earnings beat, a significant dividend hike, and an upgraded full-year outlook. The strong results have propelled the stock to new highs, reigniting the debate over its valuation in a rapidly evolving industry.
OpenText's appointment of former IBM Americas President Ayman Antoun as its new CEO, effective April 2026, has been met with a sharp sell-off. While the move brings deep cloud and AI expertise, investors appear wary of the leadership transition and strategic pivot amid ongoing portfolio restructuring and debt concerns.
Vertiv's launch of its 'Next Predict' AI service aims to transform data center maintenance. While it strengthens the company's AI infrastructure narrative, investors are weighing rich valuations against execution risks in a maturing growth cycle.
Werner Enterprises sees its fair value estimate raised significantly amid shifting analyst sentiment, driven by expectations of tighter truckload capacity and a potential freight market recovery.
Standex International (NYSE:SXI) reports robust organic growth driven by its Electronics division, alongside strategic capacity expansion and a strengthened balance sheet, culminating in a raised dividend for shareholders.
As The New York Times prepares to report its fourth-quarter earnings, investors are watching for sustained digital subscriber momentum and the media giant's ability to navigate a shifting advertising landscape.
Decentralized exchange Hyperliquid has unveiled a proposal to launch 'outcome trading,' a novel, fully-collateralized contract type designed to power prediction markets and bounded options, positioning itself amid a regulatory shift and growing competition in the event-based trading sector.
